Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 5, Pages 1125-1132
Publisher
Springer Nature
Online
2014-01-17
DOI
10.1038/bjc.2013.832
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Gap in Disease-Specific Survival Between Younger and Older Adults With De Novo Metastatic Renal Cell Carcinoma: Results of a SEER Database Analysis
- (2013) Rebecca A. Nelson et al. Clinical Genitourinary Cancer
- Disability, Health, and Multiple Chronic Conditions Among People Eligible for Both Medicare and Medicaid, 2005–2010
- (2013) Michael H. Fox et al. Preventing Chronic Disease
- Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
- (2012) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma
- (2012) Sumanta K. Pal et al. Journal of Geriatric Oncology
- Factors influencing general practitioners in the referral of elderly cancer patients
- (2011) Fleur Delva et al. BMC CANCER
- Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma
- (2011) Carlos H. Barrios et al. CANCER
- Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults
- (2011) Sumanta K. Pal et al. DRUGS & AGING
- Participation of elderly patients in registration trials for oncology drug applications in Japan
- (2010) K. Yonemori et al. ANNALS OF ONCOLOGY
- Age-related properties of the tumour vasculature in renal cell carcinoma
- (2010) Brian Meehan et al. BJU INTERNATIONAL
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers
- (2010) Maryska L.G. Janssen-Heijnen et al. JOURNAL OF CLINICAL ONCOLOGY
- The cancer survival gap between elderly and middle-aged patients in Europe is widening
- (2009) Alberto Quaglia et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma
- (2008) Esin Yildiz et al. BJU INTERNATIONAL
- Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
- (2008) T. Eisen et al. JNCI-Journal of the National Cancer Institute
- Renal Cell Carcinoma in Young and Old Patients—Is There a Difference?
- (2008) R. Houston Thompson et al. JOURNAL OF UROLOGY
- Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis
- (2008) Benjamin J. Scoll et al. JOURNAL OF UROLOGY
- Young Age Is Independent Prognostic Factor for Cancer-Specific Survival of Low-Stage Clear Cell Renal Cell Carcinoma
- (2008) Eun-Jung Jung et al. UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started